Medical Rehabilitation Research Resource (P2C Clinical Trial Optional) | RFA HD 20 004

Opportunity Information: Apply for RFA HD 20 004

The Medical Rehabilitation Research Resource (P2C Clinical Trial Optional) funding opportunity (RFA-HD-20-004) is a National Institutes of Health grant program from the Department of Health and Human Services that supports the creation or renewal of research infrastructure centers designed to strengthen medical rehabilitation research nationwide. Led collaboratively by multiple NIH institutes and centers (NICHD, NINDS, NIBIB, NIDCD, and NINR), the core purpose is to build a coordinated network of specialized resource centers that the broader rehabilitation research community can tap into for expertise, tools, and collaborative support. Rather than focusing only on a single disease area or a single institution's internal projects, the emphasis is on creating shared capacity that enables outside investigators and partners to do higher-quality, more innovative rehabilitation research that ultimately improves outcomes for people living with chronic physical disabilities.

At a practical level, applicants are expected to propose a center that provides access to "collateral expertise" that many rehabilitation teams may not have in-house, including biomedical, behavioral, engineering, and psychosocial capabilities. This signals that the NIH is looking for centers that function as hubs: places that can consult, collaborate, and provide resources across disciplines, helping research teams integrate methods and perspectives that are critical for modern rehabilitation science. The goal is to reduce fragmentation in the field by establishing a national network of centers that can share best practices, standardize or improve methods, and make it easier for researchers to launch and execute rigorous studies, including when complex technology or specialized trial design knowledge is required.

The FOA also highlights that NIH wants these centers to help close important gaps in the existing rehabilitation research portfolio, with particular attention to several high-priority topics. These include pediatric rehabilitation, recognizing that children have different developmental needs, trajectories, and family contexts than adults and often require distinct approaches to intervention and outcome measurement. Another priority is personalized medicine approaches, which in rehabilitation can involve tailoring interventions based on individual characteristics such as impairment profiles, comorbidities, genetics or biomarkers when relevant, psychosocial factors, and real-world environment. The announcement also elevates family, caregiver, and community support, reflecting the reality that rehabilitation outcomes are strongly shaped by supports outside the clinic, including caregiver training and burden, community accessibility, and social participation.

In addition, the program places strong emphasis on implementation and dissemination research, meaning it is not enough for an intervention to work in a controlled setting; it also has to be adoptable, scalable, and sustainable in real health systems and communities. Connected to that, NIH explicitly calls out clinical trial design as a priority area. Rehabilitation trials can be especially challenging because interventions are often multi-component, depend on clinician expertise and patient engagement, and may not fit neatly into traditional drug-trial models. This FOA encourages centers that can help investigators design stronger studies, choose appropriate endpoints, handle real-world variability, and address methodological issues that can limit interpretability or generalizability.

A related priority is combinatorial therapies and strategies to explore and validate combination therapies. In rehabilitation, meaningful recovery or functional improvement often comes from combining modalities, such as pairing behavioral training with neuromodulation, assistive technology, pharmacologic supports, or different therapy components delivered in coordinated sequences. NIH is signaling interest in infrastructure that can help researchers evaluate these combinations systematically rather than relying on ad hoc bundles. Finally, the FOA points to technology to track real-world outcomes, underscoring the growing role of sensors, wearables, mobile apps, and other digital measures that can capture function, activity, and participation outside the clinic. These tools can strengthen outcome assessment by reflecting daily-life performance and long-term impact, not just short snapshots in a lab or therapy session.

Administratively, this is a discretionary NIH grant mechanism categorized under education, health, income security, and social services, with the activity structured as a grant and explicitly marked "clinical trial optional," meaning proposed activities may include clinical trials but do not have to. Eligibility is broad and includes many organization types: state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; small businesses; and other applicants as described in the full announcement's eligibility clarifications. The opportunity was created March 13, 2019, with an original closing date of June 27, 2019, and anticipated up to six awards. The listed award ceiling is shown as 0, which typically indicates applicants must consult the FOA for budget structure and limits rather than relying on a fixed cap in the summary data.

Overall, the opportunity is best understood as NIH investing in shared national infrastructure for rehabilitation science: centers that make it easier for the broader field to run better studies, access cross-cutting expertise, and tackle high-impact topics like pediatric rehabilitation, tailored interventions, caregiver and community-centered supports, real-world implementation, improved trial methodology, combination therapy strategies, and modern outcome tracking technologies.

• The Department of Health and Human Services, National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173, 93.213, 93.286, 93.361, 93.853, 93.865.
• This funding opportunity was created on Mar 13, 2019.
• Applicants must submit their applications by Jun 27, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 6 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA HD 20 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: